LDS/Medical Tests/Androgen Receptor (AR) Gene Mutation Analysis

Androgen Receptor (AR) Gene Mutation Analysis

Androgen receptor (AR) Gene located on the X chromosome at the locus Xq11-12 and encodes the androgen receptor that is important in the biologic action of sex hormones. AR, also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor that is activated by binding to androgenic hormones (testosterone and 5 alpha-dihydrotestosterone) in the cytoplasm and then translocating into the nucleus. AR is involved in DNA-binding transcription factor, cell cycle/proliferation regulation, cell-to-cell signaling, and intracellular signal transduction leading to the regulation of biological processes such as development, cellular proliferation, differentiation, and apoptosis. AR also plays an important role in the development of primary and secondary sexual characteristics, spermatogenesis, hormonal regulation of sexual drive, muscle growth and the male pattering of the brain.

AR regulates genes such as prostate-specific antigen (PSA/hKlk3), hKlk2, hKlk4, prostate-specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), cell cycle regulation p27, vascular endothelial growth factor (VEGF), TMPRSS2, and Nkx3.1. Germ line mutations in AR results in androgen insensitivity syndrome, a condition that affects sexual development before birth and during puberty. Somatic mutation in the AR gene is associated with prostate cancer, polycystic ovary syndrome and an increased risk of androgenetic alopecia. Most AR gene mutation gives rise to a variable length of CAG trinucleotide repeat. Shorter length with fewer CAG repeats is associated with increased prostate cancer risk and increase length with greater CAG repeats is associated with spinal and bulbar muscular atrophy and androgen insensitivity syndrome.

  • As an aid in diagnosis of androgen insensitivity syndrome
  • As an aid in diagnosis and management of prostate adenocarcinoma and benign prostatic hyperplasia
  • As an aid in diagnosis and management of spinal and bulbar muscular atrophy (Kennedy disease)
  • Abnormal: Pathogenic variants in AR gene or increase of CAG repeat length (from 38 - >60 times) / decrease of CAG repeat length (<10).
  • Normal: No pathogenic variants in AR gene or CAG repeat length is between 10-36.

No pathogenic variants in AR gene CAG Repeats: 10-36

Target variant analysis using bi-directional Sanger sequencing for the coding regions and exon/intron boundaries of the AR gene. Repeat expansion analysis by PCR. Deletion/duplication analysis by qRT-PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) if no pathogenic variant is identified.

Whole blood, formalin-fixed paraffin-embedded tumor tissue, Paraffin block, Dried Blood Spots, Buccal Swabs

Stability (blood, blood spots, buccal swab)

  • Room temperature: 5-7 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Serum testosterone level, luteinizing hormone level, AR by Immunohistochemistry (IHC), Karyotyping.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login